- 1. PHA
- [mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes; used mainly in the study of immune mechanisms and in cell culture. ( CSP )] (UMLS (CSP) C0031858) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid =lectin;
| - 49. Pharmacy Service Providers; Pharmacist
- [An individual who is licensed to prepare and sell or dispense drugs and compounds and to make up prescriptions. ( HL7V3.0 )] (UMLS (HL7) C1554664) =Professional or Occupational Group =HealthcareProviderTaxonomyHIPAA;
=Pharmacy Service Providers; Pharmacist; General Practice;
"Pharmacy Service Providers; Pharmacist; Nuclear Pharmacy"
;"Pharmacy Service Providers; Pharmacist; Nutrition Support"
;"Pharmacy Service Providers; Pharmacist; Pharmacotherapy"
;"Pharmacy Service Providers; Pharmacist; Psychopharmacy"
; |
- 2. PHACOLYTIC GLAUCOMA
- (UMLS (ICD9CM) C0152137) =Disease or Syndrome
| - 50. Pharmacy Service Providers; Pharmacist; General Practice
- (UMLS (HL7) C1554665) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 3. phage display
- [Molecular biology technique that facilitates cloning or identification of specific proteins or peptides with a specific antigenic, ligand or protein-binding, enzymatic, or other biological property. It is based on the cloning of DNA within a phage coat protein gene so that the resulting protein is expressed as a fusion expressed on the surface of the phage. ( NCI )] (UMLS (CSP) C1519025) =Molecular Biology Research Technique =genetic technique;
| - 51. Pharmacy Service Providers; Pharmacist; Nuclear Pharmacy
- (UMLS (HL7) C1554666) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 4. Phage susceptibility typing
- [Identification, Phage susceptibility typing ( HL7V3.0 )] (UMLS (HL7) C1553141) =Laboratory Procedure =ObservationMethod;
| - 52. Pharmacy Service Providers; Pharmacist; Nutrition Support
- (UMLS (HL7) C1554667) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 5. phagocytosis
- [engulfing of microorganisms, other cells, and foreign particles by phagocytic cells (phagocytes). ( CSP )] (UMLS (CSP) C0031308) =Cell Function =endocytosis;
=autophagy | - 53. Pharmacy Service Providers; Pharmacist; Pharmacotherapy
- (UMLS (HL7) C1554668) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 6. Phagolysosome
- [A membrane-bounded intracellular vesicle formed by maturation of an early phagosome following the ingestion of particulate material by phagocytosis; during maturation, phagosomes acquire markers of late endosomes and lysosomes. [GOC:mah, PMID:12388753] ( GO )] (UMLS (NCI) C0031309) =Cell Component
| - 54. Pharmacy Service Providers; Pharmacist; Psychopharmacy
- (UMLS (HL7) C1554669) =Professional or Occupational Group =Pharmacy Service Providers; Pharmacist;
|
- 7. phagosome
- [Membrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material. ( MSH )] (UMLS (CSP) C0031310) =Cell Component
| - 55. Pharmacy Service Providers; Technician; Pharmacy
- (UMLS (HL7) C1554670) =Professional or Occupational Group =HealthcareProviderTaxonomyHIPAA;
|
- 8. Phalanx
- (UMLS (NCI) C0222682) =Body Part, Organ, or Organ Component
| - 56. Pharmacy Technician
- (UMLS (HL7) C1619825) =Intellectual Product =Pharmacy Service Providers;
|
- 9. Phalanyx
- (UMLS (HL7) C1550292) =Body Part, Organ, or Organ Component =Body Part;
| - 57. Pharmacy/treatment administration acknowledgment message
- (UMLS (HL7) C1548108) =Idea or Concept =Message type;
|
- 10. Phanerochaete chryosporium
- [ ] (UMLS (CSP) C0597971) =Fungus ;
| - 58. Pharmacy/treatment administration information
- (UMLS (HL7) C1548086) =Idea or Concept =Message type;
|
- 11. phantom limb pain
- [The sensation of pain or other unpleasant feelings in the place of a missing (phantom) limb. ( NCI )] (UMLS (NCI) C0423699) =Disease or Syndrome
| - 59. Pharmacy/treatment administration message
- (UMLS (HL7) C1548087) =Idea or Concept =Message type;
|
- 12. phantom model
- [device or object, often with properties similar to tissue, used in various imaging techniques, such as radiology and ultrasonography, to visualize or enhance visualization by simulating conditions encountered in the procedure; includes computer originated models used for such purposes; phantom models may be used for image interpretation, malignancy diagnosis, dosimetry, and as teaching aids to simulate real conditions with x-ray or ultrasonic machines. ( CSP )] (UMLS (CSP) C0597204) =Intellectual Product ;
=model;
| - 60. Pharmacy/treatment dispense acknowledgment message
- (UMLS (HL7) C1548109) =Idea or Concept =Message type;
|
- 13. Pharaoh Hound
- [The Pharaoh Hound is an athletic sight hound. The head is wedge-shaped and chiseled with large, erect ears and a powerful jaw. The flat skull and muzzle are long and slim. The coat is short and glossy in red or tan, often with white markings. It may also have a white tip on the tail, a white star on the chest, white on toes and/or a thin white line down the center of the face. Height: 21-25 inches (59-63 cm.) Weight: 45-55 pounds (20-25 kg.) ( NCI )] (UMLS (NCI) C0324411) =Mammal
| - 61. Pharmacy/treatment dispense information
- (UMLS (HL7) C1548091) =Idea or Concept =Message type;
|
- 14. Pharmaceutical
- [Pharmaceutical care performed by a pharmacist. ( HL7V3.0 )] (UMLS (HL7) C1553890) =Intellectual Product =ActMedicalServiceCode;
| - 62. Pharmacy/treatment dispense message
- (UMLS (HL7) C1548092) =Idea or Concept =Message type;
|
- 15. Pharmaceutical
- [practice of compounding and dispensing medicinal preparations; includes places where pharmaceutical drugs are sold (drug store). ( CSP )] (UMLS (NCI) C0031336) =Biomedical Occupation or Discipline =health care service;
| - 63. Pharmacy/treatment dose information
- (UMLS (HL7) C1548096) =Idea or Concept =Message type;
|
- 16. Pharmaceutical error
- (UMLS (HL7) C1547269) =Intellectual Product =Risk Management Incident Code;
| - 64. Pharmacy/treatment encoded order acknowledgment message
- (UMLS (HL7) C1548110) =Idea or Concept =Message type;
|
- 17. pharmaceutical policy
- [ ] (UMLS (CSP) C0600206) =Governmental or Regulatory Activity
| - 65. Pharmacy/treatment encoded order information
- (UMLS (HL7) C1548095) =Idea or Concept =Message type;
|
- 18. Pharmaceutical substance is in the formulary
- (UMLS (HL7) C1547555) =Idea or Concept =Formulary Status;
| - 66. Pharmacy/treatment encoded order message
- (UMLS (HL7) C1548090) =Idea or Concept =Message type;
|
- 19. Pharmaceutical substance is in the formulary, but guidelines apply
- (UMLS (HL7) C1547552) =Idea or Concept =Formulary Status;
| - 67. Pharmacy/treatment give acknowledgment message
- (UMLS (HL7) C1548111) =Idea or Concept =Message type;
|
- 20. Pharmaceutical substance is in the formulary, but restrictions apply
- (UMLS (HL7) C1547554) =Idea or Concept =Formulary Status;
| - 68. Pharmacy/treatment give message
- (UMLS (HL7) C1548097) =Idea or Concept =Message type;
|
- 21. Pharmaceutical substance is NOT in the formulary
- (UMLS (HL7) C1547553) =Idea or Concept =Formulary Status;
| - 69. Pharmacy/treatment order acknowledgment message
- (UMLS (HL7) C1548061) =Idea or Concept =Message type;
|
- 22. Pharmaceutical Substances
- (UMLS (HL7) C1547857) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 70. Pharmacy/treatment order message
- (UMLS (HL7) C1548059) =Idea or Concept =Message type;
|
- 23. Pharmaceuticals
- [ ] (UMLS (ICD9CM) C1135440) =Therapeutic or Preventive Procedure
| - 71. Pharmacy/treatment order response
- (UMLS (HL7) C1548098) =Idea or Concept =Message type;
|
- 24. Pharmacist
- (UMLS (HL7) C1546966) =Idea or Concept =Primary Observer's Qualification;
| - 72. Pharyngeal Arch
- (UMLS (NCI) C0080322) =Embryonic Structure ;
|
- 25. Pharmacist
- [An individual who is licensed to prepare and sell or dispense drugs and compounds and to make up prescriptions.Source: Dorland's Illustrated Medical Dictionary, 26th Edition, Philadelphia: W.. Saunders Company, 1981. ( HL7V3.0 )] (UMLS (HL7) C1610714) =Intellectual Product =Pharmacy Service Providers;
=Nutrition Support;
Pharmacotherapy;
Psychopharmacy;
General Practice;
Nuclear Pharmacy;
| - 73. PHARYNGEAL BIOPSY
- [ ] (UMLS (ICD9CM) C0192210) =Diagnostic Procedure
|
- 26. Pharmacist
- [persons legally qualified by education and training to engage in the practice of pharmacy. ( CSP )] (UMLS (NCI) C0031323) =Professional or Occupational Group =health care personnel;
| - 74. Pharyngeal Cancer Stage I
- [Stage 1 includes T1, N0, M0. T1: Tumor confined to the nasopharynx. ( NCI )] (UMLS (NCI) C0854998) Stage I Pharyngeal Cancer;
=Neoplastic Process |
- 27. Pharmacist license number
- (UMLS (HL7) C1549744) =Idea or Concept =Identifier type;
| - 75. Pharyngeal Cancer Stage II
- [Stage 2 includes T2a,T2b,N0,M0/T1,T2,T2a,T2b,N1,M0. T2: Tumor extends to soft tissues of oropharynx and/or nasal fossa. T2a: without parapharyngeal extension. T2b: with parapharyngeal extension. N1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. ( NCI )] (UMLS (NCI) C1378108) Stage II Carcinoma of Pharynx;
Stage II Carcinoma of the Pharynx;
Stage II Pharyngeal Cancer;
Stage II Pharyngeal Carcinoma;
Stage II Pharynx Carcinoma =Neoplastic Process |
- 28. pharmacodynamics
- [The study of the biochemical and physiological effects of drugs and the mechanisms of their actions, including the correlation of actions and effects of drugs with their chemical structure, also, such effects on the actions of a particular drug or drugs. ( NCI )] (UMLS (CSP) C0851347) =Biologic Function
| - 76. Pharyngeal Cancer Stage III
- [Stage 3 includes T1,T2a,T2b,N2,M0/T3,N0,N1,N2,M0. T3: Tumor invades bony structures and/or paranasal sinuses. N2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. ( NCI )] (UMLS (NCI) C1378109) Stage III Carcinoma of Pharynx;
Stage III Carcinoma of the Pharynx;
Stage III Pharyngeal Cancer;
Stage III Pharyngeal Carcinoma;
Stage III Pharynx Carcinoma =Neoplastic Process |
- 29. pharmacogenetics
- [branch of genetics (the branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance) which deals with the genetic variability in individual responses to drugs and drug metabolism. ( CSP )] (UMLS (CSP) C0031325) =Biomedical Occupation or Discipline =Genetics;
Pharmacologic | - 77. Pharyngeal Cancer Stage IVA
- (UMLS (NCI) C1336359) Stage IVA Carcinoma of Pharynx;
Stage IVA Carcinoma of the Pharynx;
Stage IVA Pharyngeal Cancer;
Stage IVA Pharyngeal Carcinoma;
Stage IVA Pharynx Carcinoma =Neoplastic Process |
- 30. Pharmacogenomics
- [While pharmacogenetics largely focuses on candidate genes, such as drug-metabolizing enzymes, pharmacogenomics broadens the scope of study to include all genes (ie, the genome). The latter approach takes into account that a patient's response to any given drug depends on numerous proteins in the body, such as metabolizing enzymes, transporters, receptors, and entire signaling networks mediating the response. Furthermore, genetic defects that underlie the disease process could determine the drug's effects even if they have no direct bearing on its mechanism of action. (from Medscape Pharmacotherapy) ( NCI )] (UMLS (NCI) C1138555) =Biomedical Occupation or Discipline ;
| - 78. Pharyngeal Cancer Stage IVB
- (UMLS (NCI) C1336390) Stage IVB Carcinoma of Pharynx;
Stage IVB Carcinoma of the Pharynx;
Stage IVB Pharyngeal Cancer;
Stage IVB Pharyngeal Carcinoma;
Stage IVB Pharynx Carcinoma =Neoplastic Process |
- 31. pharmacognosy
- [The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY. ( MSH )] (UMLS (CSP) C0031326) =Biomedical Occupation or Discipline
| - 79. Pharyngeal Cancer Stage IVC
- (UMLS (NCI) C1336409) Stage IVC Carcinoma of Pharynx;
Stage IVC Carcinoma of the Pharynx;
Stage IVC Pharyngeal Cancer;
Stage IVC Pharyngeal Carcinoma;
Stage IVC Pharynx Carcinoma =Neoplastic Process |
- 32. PHARMACOKINETIC
- [A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI) ( NCI )] (UMLS (NCI) C0201734) =Research Activity
| - 80. Pharyngeal Cancer, Recurrent
- (UMLS (NCI) C0854996) Recurrent Cancer of Pharynx;
Recurrent Cancer of the Pharynx;
Recurrent Carcinoma of Pharynx;
Recurrent Carcinoma of the Pharynx;
Recurrent Pharyngeal Cancer;
Recurrent Pharyngeal Carcinoma;
Recurrent Pharynx Cancer;
Recurrent Pharynx Carcinoma;
Relapsed Cancer of Pharynx;
Relapsed Cancer of the Pharynx;
Relapsed Carcinoma of Pharynx;
Relapsed Carcinoma of the Pharynx;
Relapsed Pharyngeal Cancer;
Relapsed Pharyngeal Carcinoma;
Relapsed Pharynx Cancer;
Relapsed Pharynx Carcinoma =Neoplastic Process |
- 33. Pharmacologic
- [biological effects of drugs in living organisms or tissues; use this term mainly for intended, desired effects; for harmful or undesired effects, see DRUG ADVERSE EFFECT or TOXICOLOGY. ( CSP )] (UMLS (NCI) C0031330) =Biomedical Occupation or Discipline =Medical Science;
=drug administration route;
drug resistance;
drug tolerance;
neuropharmacology;
pharmacogenetics;
mechanism of action;
Pharmacology-Psychopharmacology;
chemical stimulation;
drug adverse effect;
DRUG WITHDRAWAL;
;
biliary tract pharmacology;
blood/lymphatic pharmacology;
cardiovascular pharmacology;
connective tissue pharmacology;
dental pharmacology;
drug classification;
ear pharmacology;
embryo/fetus pharmacology;
endocrine pharmacology;
eye pharmacology;
gastrointestinal pharmacology;
liver pharmacology;
muscle pharmacology;
neoplasm/cancer pharmacology;
pediatric pharmacology;
physical chemical interaction;
radiopharmacology;
receptor sensitivity;
reproductive system pharmacology;
respiratory pharmacology;
skeletal pharmacology;
skin pharmacology;
urinary tract pharmacology;
immunopharmacology;
Chemical Dependence;
| - 81. PHARYNGEAL DIVERTICULEC
- [ ] (UMLS (ICD9CM) C0396338) =Therapeutic or Preventive Procedure
|
- 34. Pharmacologist
- [A physician, scientist, or healthcare provider that investigates the mechanisms underlying the effects of drugs and chemicals on biological or living systems. This knowledge is employed to help design and evaluate drugs for the prevention and treatment of disease. ( NCI )] (UMLS (NCI) C0260120) =Professional or Occupational Group ;
| - 82. Pharyngeal Groove
- (UMLS (NCI) C1280559) =Embryonic Structure
|
- 35. Pharmacology and Toxicology
- [The science concerned with drugs together with the science concerned with the detection, chemical composition, and pharmacologic action of toxic substances or poisons and the treatment and prevention of toxic manifestations. ( NCI )] (UMLS (NCI) C0678735) =Occupation or Discipline
| - 83. Pharyngeal Muscle
- [The muscles of the pharynx, the inferior, middle and superior constrictors, salpingopharyngeus, and stylopharyngeus. (MeSH) ( NCI )] (UMLS (NCI) C0031346) =Body Part, Organ, or Organ Component ;
|
- 36. Pharmacology-Psychopharmacology
- [study of the effects of drugs on mental and behavioral activity. ( CSP )] (UMLS (NCI) C0033929) =Biomedical Occupation or Discipline ;
=Pharmacologic;
biological basis of behavior | - 84. Pharyngeal Pouch
- (UMLS (NCI) C0231067) =Embryonic Structure
|
- 37. pharmacophore
- [ ] (UMLS (CSP) C0599740) =Receptor ;
| - 85. pharyngitis
- [inflammation of the throat. ( CSP )] (UMLS (CSP) C0031350) =Disease or Syndrome ;
=DISEASE OF PHARYNX NOS;
respiratory infection;
oral pharyngeal disorder;
|
- 38. Pharmacotherapy
- (UMLS (HL7) C1552222) =Intellectual Product =Pharmacist;
| - 86. PHARYNGOCONJUNCT FEVER
- (UMLS (ICD9CM) C0031351) =Disease or Syndrome ;
|
- 39. Pharmacy
- (UMLS (HL7) C1547997) =Intellectual Product =Diagnostic Service Section ID;
| - 87. Pharyngoesophageal Diverticulum
- [A DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus. ( MSH )] (UMLS (NCI) C0085232) =Disease or Syndrome =Diverticulum, Esophageal;
|
- 40. Pharmacy
- [Location where healthcare service was delivered, identified as a pharmacy. ( HL7V3.0 )] (UMLS (HL7) C1555595) =Intellectual Product =DedicatedNonClinicalLocationRoleType;
◊ [A facility used by pharmacists for the compounding and dispensing of medicinal preparations (drug store). A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs through a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located. ( HL7V3.0 )] (UMLS (HL7) C1609627) Intellectual Product Supplier; | - 88. PHARYNGOSCOPY
- [ ] (UMLS (ICD9CM) C0192232) =Diagnostic Procedure
|
- 41. pharmacy administration
- [business, administration, and management of pharmacy services. ( CSP )] (UMLS (CSP) C0031337) =Occupational Activity =health administration;
| - 89. PHARYNGOTOMY
- [ ] (UMLS (ICD9CM) C0192198) =Therapeutic or Preventive Procedure
|
- 42. Pharmacy administration information
- (UMLS (HL7) C1546468) =Idea or Concept =What subject filter;
| - 90. pharynx
- [funnel-shaped fibromuscular tube that conducts food to the esophagus, and air to the larnyx and lungs. ( CSP )] (UMLS (NCI) C0031354) =Body Part, Organ, or Organ Component ;
=Body System, Gastrointestinal;
Body System, Pulmonary;
Body Part;
=Nasopharyngeal;
oral pharyngeal;
|
- 43. Pharmacy dispense information
- (UMLS (HL7) C1546469) =Idea or Concept =What subject filter;
| - 91. Pharynx necrosis
- (UMLS (NCI) C1397204) Pharynx Necrosis Adverse Event =Finding
|
- 44. Pharmacy encoded order information
- (UMLS (HL7) C1546470) =Idea or Concept =What subject filter;
| - 92. Phase
- [A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle. ( NCI )] (UMLS (NCI) C0205390) =Temporal Concept
|
- 45. Pharmacy give information
- (UMLS (HL7) C1546472) =Idea or Concept =What subject filter;
| - 93. phase change
- [in physical chemistry, alteration of a physically or chemically distinct homogeneous and mechanically separable part of a system, for example the ice and steam phases of water. ( CSP )] (UMLS (CSP) C0597205) =Quantitative Concept ;
=Physical Phenomenon;
=crystallization;
Freeze Technique;
precipitation;
evaporation;
|
- 46. Pharmacy Order Types
- (UMLS (HL7) C1547858) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Drug;
Other solution as medication orders;
IV Large Volume Solutions;
| - 94. Phase of life problem adult
- (UMLS (ICPC) C0497324) (Phase of life problem adult; BIZITZAKO FASEKO ARAZOA:HELDUAK; Problem i en livsfase hos voksen; Levensfaseprobleem volwassene; AIKUISEN ELAMANVAIHEKRIISI; Probleme de phase de vie adulte; Lebensphasenbezog Probl Erwachsener; shalav shel beayot xaim bimvugar; felnott korosztalyi problema; Problema di fase di vita in adulto; LIVSFASEPROBLEM HOS VOKSNE; Prob numa fase da vida do adulto; Cambio estado/situacion adulto; LIVSKRIS HOS VUXEN) =Sign or Symptom =Symptoms and Complaints Component; PSYCHOLOGICAL
|
- 47. Pharmacy prescription information
- (UMLS (HL7) C1546473) =Idea or Concept =What subject filter;
| - 95. Phaseolus
- [A plant genus in the family FABACEAE which is the source of edible beans and the lectin PHYTOHEMAGGLUTININS. ( MSH )] (UMLS (CSP) C0031357) =Plant ;
|
- 48. Pharmacy Service Providers
- [A broad category grouping providers who render services relating to the preparation and dispensing of drugs. ( HL7V3.0 )] (UMLS (HL7) C1556039) =Intellectual Product =NUCC Health Care Provider Taxonomy;
=Pharmacist;
Pharmacy Technician;
| - 96. Phasianidae
- [ ] (UMLS (CSP) C0325635) =Bird
|
home
